Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAn entry for revision v3.7.0 has been added to the study history. The previous revision v3.6.6 is no longer listed.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.6.6 was added to the record history, replacing the previous revision entry 'v3.6.5'. This reflects a minor update to the page's revision metadata rather than a change to the study data.SummaryDifference0.1%

- Check71 days agoChange DetectedThe study record history now shows the latest revision as v3.6.5, replacing the previous latest revision v3.6.4. This reflects an administrative update to the versioning of the record rather than changes to study data or eligibility.SummaryDifference0.1%

- Check86 days agoChange DetectedThe study record history adds a new revision entry labeled v3.6.4, replacing the previous v3.6.3. This reflects a small update to the page record.SummaryDifference0.1%

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.